Table 5.

Safety outcomes

Parameter, n (%)	DCV+SOF±RBV	DCV+ASV	DCV+ASV+BCV ±RBV	DCV+ASV+pegIFNα/RBV	DCV+pegIFNα/RBV
	N = 237	N = 389	N = 267	N = 199	N = 411
Death	1	5	0	1	4
Liver‐related	0	2a	0	0	1b
Other	1c	3d	0	1e	3f
SAEsg	0	0	0	0	0

^aAdenocarcinoma liver after post‐HCV cirrhosis (n = 1); liver disease (n = 1).

^bLiver disease.

^cSuspected chronic obstructive pulmonary disease.

^dCholangiocellular carcinoma (n = 1); septic shock (n = 1); upper gastrointestinal bleeding (n = 1).

^eSudden cardiac arrest.

^fHeart attack (n = 1); chronic kidney failure (n = 1); carcinoma of the cervix (n = 1).

^gTreatment‐related.